Booster Vaccination

[gtranslate]
WhatsApp
Email
[brochureHTML]
  1. Rothstein E, Edwards K. Health Burden of Pertussis in Adolescents and Adults 2005. The Paedatric Infectious Disease Journal. 24:S44-S47.
  2. Guiso N, et al. The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis 2011. Vaccines. 29:1115-1121.
  3. Soofie N, et al. The Burden of Pertussis Hospitalization in HIV-Exposed and HIVUnexposed South African Infants. CID 2016;63 (Suppl 4):S165-S173.
  4. Stark K, et al. Seroprevalence and determinants of diphtheria, tetanus and poliomyelitis antibodies among adults in Berlin, Germany.
    Vaccine. 1999;17;844-850.
  5. WHO, Diphtheria vaccine position paper, Weekly Epidemiological Record. 2006;81(3):29.
  6. WHO, Polio vaccines and polio immunisation in the pre-eradication era: WHO position paper. Weekly Epidemiology Record 2010.
  7. WHO, International travel and health. Available at http://www.who.int/ith/disease/polio/en/index.html. Accessed July 2013.
  8. Kretsinger K, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria
    toxoid and acellular pertussis vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-17):1-37.

sanofi-aventis south africa (pty) ltd, reg. no.: 1996/010381/07. 2 Bond Street, Grand Central Ext. 1, Midrand,
1685. Tel: (011) 256 3700. Fax: (011) 256 3707. www.sanofipasteur.com. SPZA.VACCI.19.12.0118

Related Brochures

[sidebarBrochures]